Skip to content

Computer-Aided Prevention System

Study on Improved Prevention Methods for Cerebro-cardiovascular Diseases Based on a Computer-aided Prevention System

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02444715
Acronym
CAPSYS
Enrollment
94
Registered
2015-05-14
Start date
2013-01-31
Completion date
2014-08-31
Last updated
2016-02-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Diseases, Cerebrovascular Diseases, CVD Risk Factors, Stroke

Keywords

Lifestyle coaching, Phone-based system, CVD prevention, Patient-centered decision support

Brief summary

Stroke is one of the most frequent and life-threatening diseases in Europe. About four stroke events occur per day in Luxembourg alone, and about 30% of these patients are affected by recurrent stroke within the following five years. Thus, new methods of primary and secondary prevention are needed to better control lifestyle-related risk factors. The development and maintenance of a healthy lifestyle (smoking cessation, healthy nutrition, moderate physical exercises etc.) is a major objective concerning the primary and secondary prevention of cerebro- and cardiovascular diseases. CAPSYS is a computer-based lifestyle coaching system developed by researchers from the Public Research Centre (CRP) Henri Tudor in Luxembourg in collaboration with neurologists from the Centre Hospitalier de Luxembourg (CHL), which aims at supporting patients in performing appropriate behavior changes in order to minimize their individual risk factors. Patients can access CAPSYS by dialing a local-rate telephone number and answer to a set of previously known questions concerning their current nutrition, physical activity, blood pressure, smoking etc. In an interactive voice response approach, questions are issued by the system in natural language using text-to-speech, and the patient can provide the required values using the phone keypad. Based on the gathered values for each patient, the system automatically generates personalized verbal feedback at runtime and presents it to the patient during the phone dialog. Depending on the individual development of the patient's risk factors, the system feedback can contain advice for improvement, praise for healthy behavior and motivation to pursue a certain goal. The user acceptance and effectiveness of the CAPSYS system is evaluated in a six-month randomized controlled study with participants recruited at CHL's neurology department.

Interventions

BEHAVIORALStandard care

Participants receive only the usual care including blood analyses, blood pressure controls and individual advice on healthy lifestyle during the outpatient treatment given by the neurologist, by the general practitioner and by other physicians.

BEHAVIORALCAPSYS

In addition to the usual care, patients are asked to call the CAPSYS system twice a week.

Sponsors

Centre Hospitalier du Luxembourg
CollaboratorOTHER
Lübomira Spassova
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* At high risk of stroke: * Already suffered a stroke or Transient Ischemic Attack (TIA) or * At least two risk factors for stroke: * High blood pressure * Overweight * Low physical activity * Smoking * Unhealthy diet

Exclusion criteria

* Inability to fill out or to understand the informed consent * No signed informed consent * Dementia

Design outcomes

Primary

MeasureTime frame
Change in BMI Valuebaseline and 6 months
Change in Systolic Blood Pressurebaseline and 6 months
Change in HDL Levelbaseline and 6 months
Change in LDL Levelbaseline and 6 months
Change in Triglyceride Levelbaseline and 6 months
Change in HbA1c Levelbaseline and 6 months
Change in Glycaemia Levelbaseline and 6 months

Secondary

MeasureTime frameDescription
Change in Fruits and Vegetables Consumptionbaseline and 6 monthsSelf-reported weekly portions of fruits and vegetables consumption (During the recruiting interview, participants were instructed in estimating the size of a portion of fruits or vegetables and they were provided an information booklet on this topic.)
Change in Whole Grain Food Consumptionbaseline and 6 monthsSelf-reported weekly portions of whole grain food consumption (During the recruiting interview, participants were instructed in estimating the size of a portion of whole grain food and they were provided an information booklet on this topic.)
Change in Sweets Consumptionbaseline and 6 monthsSelf-reported weekly portions of sweets consumption (During the recruiting interview, participants were instructed in estimating the size of a portion of sweets and they were provided an information booklet on this topic.)
Change in Duration of Physical Activitybaseline and 6 monthsSelf-reported weekly duration of physical activity of medium or high intensity
Change in Quality of Lifebaseline and 6 monthsThe QoL was measured using the standardised EQ-5D-5L instrument provided by the EuroQol Group. In this context, the health value was specified by the participants on a subjective scale ranging from 0 (The worst health you can imagine) to 100 (The best health you can imagine).

Other

MeasureTime frameDescription
Usability: SUS Score6 monthsThe usability of the intervention was assessed based on the standardised System Usability Scale (SUS). SUS scores were not collected in the SC group because the SC participants were not using CAPSYS and hence were not able to assess its usability. The System Usability Scale (SUS) provides a quick and dirty, reliable tool for measuring the usability. It consists of a 10 item questionnaire with five response options for respondents; from Strongly agree to Strongly disagree. Originally created by John Brooke in 1986, it allows to evaluate a wide variety of products and services, including hardware, software, mobile devices, websites and applications. The total SUS score computed based on the responses provided to each of the 10 items can range from 0 (worst) to 100 (best). Based on research, a SUS score above a 68 would be considered above average and anything below 68 is below average.

Participant flow

Participants by arm

ArmCount
Standard Care (SC)
Standard care: Participants receive only the usual care including blood analyses, blood pressure controls and individual advice on healthy lifestyle during the outpatient treatment given by the neurologist, by the general practitioner and by other physicians.
46
Interventional Care (IC)
CAPSYS: In addition to the usual care, patients are asked to call the CAPSYS system twice a week.
48
Total94

Baseline characteristics

CharacteristicStandard Care (SC)Interventional Care (IC)Total
Age, Continuous59.6 years
STANDARD_DEVIATION 12.1
60.7 years
STANDARD_DEVIATION 11.3
60.2 years
STANDARD_DEVIATION 11.6
Sex: Female, Male
Female
17 Participants14 Participants31 Participants
Sex: Female, Male
Male
29 Participants34 Participants63 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 460 / 48
serious
Total, serious adverse events
0 / 460 / 48

Outcome results

Primary

Change in BMI Value

Time frame: baseline and 6 months

Population: For participants who did not provide final questionnaires, data was retrieved from medical records. Weight data is missing for 9 of the 46 SC and 15 of the 48 IC participants who started the study.

ArmMeasureValue (MEAN)Dispersion
Standard Care (SC)Change in BMI Value0.05 kg/m^2Standard Deviation 1.61
Interventional Care (IC)Change in BMI Value-0.26 kg/m^2Standard Deviation 1.3
Comparison: H0: no change between baseline and post-interventionp-value: 0.9t-test, 2 sided
Comparison: H0: no change between baseline and post-interventionp-value: 0.43t-test, 2 sided
Primary

Change in Glycaemia Level

Time frame: baseline and 6 months

Population: For participants who did not provide final questionnaires, data was retrieved from medical records. Glycaemia data is missing for 6 of the 46 SC and 13 of the 48 IC participants who started the study.

ArmMeasureValue (MEDIAN)
Standard Care (SC)Change in Glycaemia Level-0.5 mg/dl
Interventional Care (IC)Change in Glycaemia Level-2 mg/dl
Comparison: H0: no change between baseline and post-interventionp-value: 0.78Wilcoxon (Mann-Whitney)
Comparison: H0: no change between baseline and post-interventionp-value: 0.19Wilcoxon (Mann-Whitney)
Primary

Change in HbA1c Level

Time frame: baseline and 6 months

Population: For participants who did not provide final questionnaires, data was retrieved from medical records. HbA1c data is missing for 21 of the 46 SC and 21 of the 48 IC participants who started the study.

ArmMeasureValue (MEDIAN)
Standard Care (SC)Change in HbA1c Level-0.1 percent HbA1c
Interventional Care (IC)Change in HbA1c Level-0.1 percent HbA1c
Comparison: H0: no change between baseline and post-interventionp-value: 0.92Wilcoxon (Mann-Whitney)
Comparison: H0: no change between baseline and post-interventionp-value: 0.37Wilcoxon (Mann-Whitney)
Primary

Change in HDL Level

Time frame: baseline and 6 months

Population: For participants who did not provide final questionnaires, data was retrieved from medical records. HDL data is missing for 5 of the 46 SC and 11 of the 48 IC participants who started the study.

ArmMeasureValue (MEDIAN)
Standard Care (SC)Change in HDL Level1 mg/dl
Interventional Care (IC)Change in HDL Level-2 mg/dl
Comparison: H0: no change between baseline and post-interventionp-value: 0.53Wilcoxon (Mann-Whitney)
Comparison: H0: no change between baseline and post-interventionp-value: 0.44Wilcoxon (Mann-Whitney)
Primary

Change in LDL Level

Time frame: baseline and 6 months

Population: For participants who did not provide final questionnaires, data was retrieved from medical records. LDL data is missing for 5 of the 46 SC and 11 of the 48 IC participants who started the study.

ArmMeasureValue (MEDIAN)
Standard Care (SC)Change in LDL Level-1 mg/dl
Interventional Care (IC)Change in LDL Level-6 mg/dl
Comparison: H0: no change between baseline and post-interventionp-value: 0.76Wilcoxon (Mann-Whitney)
Comparison: H0: no change between baseline and post-interventionp-value: 0.04Wilcoxon (Mann-Whitney)
Primary

Change in Systolic Blood Pressure

Time frame: baseline and 6 months

Population: Blood pressure data is missing for 4 of the 36 SC and 4 of the 32 IC participants who provided final questionnaires.

ArmMeasureValue (MEAN)Dispersion
Standard Care (SC)Change in Systolic Blood Pressure0.19 mmHgStandard Deviation 21.34
Interventional Care (IC)Change in Systolic Blood Pressure-9 mmHgStandard Deviation 21.37
Comparison: H0: no change between baseline and post-interventionp-value: 0.96t-test, 2 sided
Comparison: H0: no change between baseline and post-interventionp-value: 0.03t-test, 2 sided
Primary

Change in Triglyceride Level

Time frame: baseline and 6 months

Population: For participants who did not provide final questionnaires, data was retrieved from medical records. Triglyceride data is missing for 16 of the 46 SC and 16 of the 48 IC participants who started the study.

ArmMeasureValue (MEDIAN)
Standard Care (SC)Change in Triglyceride Level-1 mg/dl
Interventional Care (IC)Change in Triglyceride Level-11 mg/dl
Comparison: H0: no change between baseline and post-interventionp-value: 0.39Wilcoxon (Mann-Whitney)
Comparison: H0: no change between baseline and post-interventionp-value: 0.04Wilcoxon (Mann-Whitney)
Secondary

Change in Duration of Physical Activity

Self-reported weekly duration of physical activity of medium or high intensity

Time frame: baseline and 6 months

Population: Data on physical activity was retrieved from final questionnaires. Hence, physical activity data is missing for the 10 SC and 16 IC participants who did not provide final questionnaires.

ArmMeasureGroupValue (MEDIAN)
Standard Care (SC)Change in Duration of Physical Activitymedium intensity0 minutes
Standard Care (SC)Change in Duration of Physical Activityhigh intensity0 minutes
Interventional Care (IC)Change in Duration of Physical Activitymedium intensity0 minutes
Interventional Care (IC)Change in Duration of Physical Activityhigh intensity0 minutes
Comparison: Medium intensity~H0: no change between baseline and post-interventionp-value: 0.37Wilcoxon (Mann-Whitney)
Comparison: Medium intensity~H0: no change between baseline and post-interventionp-value: 0.34Wilcoxon (Mann-Whitney)
Comparison: High intensity~H0: no change between baseline and post-interventionp-value: 0.37Wilcoxon (Mann-Whitney)
Comparison: High intensity~H0: no change between baseline and post-interventionp-value: 0.59Wilcoxon (Mann-Whitney)
Secondary

Change in Fruits and Vegetables Consumption

Self-reported weekly portions of fruits and vegetables consumption (During the recruiting interview, participants were instructed in estimating the size of a portion of fruits or vegetables and they were provided an information booklet on this topic.)

Time frame: baseline and 6 months

Population: Data on fruits and vegetables consumption was retrieved from final questionnaires. Hence, food consumption data is missing for the 10 SC and 16 IC participants who did not provide final questionnaires.

ArmMeasureValue (MEDIAN)
Standard Care (SC)Change in Fruits and Vegetables Consumption0 portions
Interventional Care (IC)Change in Fruits and Vegetables Consumption3.5 portions
Comparison: H0: no change between baseline and post-interventionp-value: 0.67Wilcoxon (Mann-Whitney)
Comparison: H0: no change between baseline and post-interventionp-value: 0.04Wilcoxon (Mann-Whitney)
Secondary

Change in Quality of Life

The QoL was measured using the standardised EQ-5D-5L instrument provided by the EuroQol Group. In this context, the health value was specified by the participants on a subjective scale ranging from 0 (The worst health you can imagine) to 100 (The best health you can imagine).

Time frame: baseline and 6 months

Population: Data on quality of life was retrieved from final questionnaires. Hence, QoL data is missing for the 10 SC and 16 IC participants who did not provide final questionnaires.

ArmMeasureValue (MEDIAN)
Standard Care (SC)Change in Quality of Life0 units on a scale (health value)
Interventional Care (IC)Change in Quality of Life0 units on a scale (health value)
Comparison: H0: no change between baseline and post-interventionp-value: 0.64Wilcoxon (Mann-Whitney)
Comparison: H0: no change between baseline and post-interventionp-value: 0.14Wilcoxon (Mann-Whitney)
Secondary

Change in Sweets Consumption

Self-reported weekly portions of sweets consumption (During the recruiting interview, participants were instructed in estimating the size of a portion of sweets and they were provided an information booklet on this topic.)

Time frame: baseline and 6 months

Population: Data on sweets consumption was retrieved from final questionnaires. Hence, food consumption data is missing for the 10 SC and 16 IC participants who did not provide final questionnaires.

ArmMeasureValue (MEDIAN)
Standard Care (SC)Change in Sweets Consumption0 portions
Interventional Care (IC)Change in Sweets Consumption0 portions
Comparison: H0: no change between baseline and post-interventionp-value: 0.06Wilcoxon (Mann-Whitney)
Comparison: H0: no change between baseline and post-interventionp-value: 0.04Wilcoxon (Mann-Whitney)
Secondary

Change in Whole Grain Food Consumption

Self-reported weekly portions of whole grain food consumption (During the recruiting interview, participants were instructed in estimating the size of a portion of whole grain food and they were provided an information booklet on this topic.)

Time frame: baseline and 6 months

Population: Data on whole grain food consumption was retrieved from final questionnaires. Hence, food consumption data is missing for the 10 SC and 16 IC participants who did not provide final questionnaires.

ArmMeasureValue (MEDIAN)
Standard Care (SC)Change in Whole Grain Food Consumption0 portions
Interventional Care (IC)Change in Whole Grain Food Consumption1 portions
Comparison: H0: no change between baseline and post-interventionp-value: 0.26Wilcoxon (Mann-Whitney)
Comparison: H0: no change between baseline and post-interventionp-value: 0.07Wilcoxon (Mann-Whitney)
Other Pre-specified

Usability: SUS Score

The usability of the intervention was assessed based on the standardised System Usability Scale (SUS). SUS scores were not collected in the SC group because the SC participants were not using CAPSYS and hence were not able to assess its usability. The System Usability Scale (SUS) provides a quick and dirty, reliable tool for measuring the usability. It consists of a 10 item questionnaire with five response options for respondents; from Strongly agree to Strongly disagree. Originally created by John Brooke in 1986, it allows to evaluate a wide variety of products and services, including hardware, software, mobile devices, websites and applications. The total SUS score computed based on the responses provided to each of the 10 items can range from 0 (worst) to 100 (best). Based on research, a SUS score above a 68 would be considered above average and anything below 68 is below average.

Time frame: 6 months

Population: SUS questionnaires are missing, incomplete or invalid for 6 of the 32 IC participants who provided final questionnaires.

ArmMeasureValue (MEAN)Dispersion
Standard Care (SC)Usability: SUS Score80.1 units on a scale (total SUS score)Standard Deviation 16.22

Source: ClinicalTrials.gov · Data processed: Mar 2, 2026